Incredible Growth Of Medical Cannabis Market 2026 Growing With Major Eminent Key Players
According to the
U.S., marijuana was the most widely used drug globally in 2014 with
around 183 million users. Such a large user base makes it highly
lucrative taxable opportunity, which is influencing various
governments worldwide to initiate studies regarding legalization of
the drug for medicinal use. The National Institute on Drug Abuse is
conducting research on cannabis (marijuana) to treat numerous
diseases and conditions such as autoimmune disease, pain,
inflammation, seizures, mental disorders, and substance abuse
disorders. Regulatory compliance is a key factor that influences
cost, quality, and safety of cannabis (marijuana) medicines, as well
as the capacity for the manufacturers in the medical cannabis market
to be responsive, scalable, and innovative.
Market
Dynamics
According to the
Medical Marijuana, Inc., an estimated size of the legal marijuana
industry in the U.S. was US$ 7.1 billion in 2016 with increase of 25%
Y-o-Y. In 2016, 28 states in the U.S. have legalized marijuana for
medicinal purpose with some more gearing up for votes on the
recreational use of marijuana. California, Nevada, Maine, and
Massachusetts states in November 2016, voted to legalize the
recreational use of marijuana. The accelerated pace of legalization
of cannabis (marijuana) in the U.S. has attracted the attention of
global investors in the medical cannabis market. However, lack of
formulation of a comprehensive law pertaining to medical marijuana in
some states inhibits patient access to the drug.
Request For a
Sample Copy of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/40
Legalization
of medicinal cannabis in various economies is expected to drive the
market growth
Some of the major
factors driving growth of the market include increasing approval of
medicinal cannabis products and increasing research and development
activities. For instance, in March 2017, a law that allows the use of
cannabis plant was signed by the German parliament. This would in
turn allow the healthcare professionals to prescribe medicinal
cannabis products to the patients suffering from severe health issues
such as chronic pain, vomiting, and nausea
Key features
of the study:
-
This report provides in-depth analysis of medicinal cannabis in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
-
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
-
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
-
It profiles leading players in the global medicinal cannabis for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Potential medical
cannabis markets other than the U.S. include Canada, Israel,
Australia, and Spain. Mexico is also in process to consider the
legalization of cannabis. For instance, in February 2016, Medical
Marijuana, Inc. launched the HempMeds Mexico- a CBD hemp oil product
in the Mexico. With the launch of HempMeds Mexico, company is
intended to expand its cannabis business in the Latin America, by
establishing the labs, manufacturing, sales and distribution
facilities in the Mexico, in coming years. Other economies are
expected to consider legalization of the drug, once conclusive
evidence regarding the safety and efficacy of cannabis are obtained
through extensive research.
Some of the key
players operating in the global medical cannabis market include BOL
Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy
Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC
Pharmaceuticals Limited, GW Pharmaceuticals, plc, and Medical
Marijuana Inc.
Click To Read More On Medical
Cannabis Market
About Coherent
Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment